Answers are grounded in this paper and cite their sources.
This study develops and evaluates a dynamic downside-minimizing portfolio through five stages. Starting with a 4-asset universe of equity, bonds, gold, and a volatility instrument, the portfolio is expanded to 13 and then 21 assets while incorporating mean-semivariance optimization, Asian arithmetic-average puts, American puts valued with Longstaff–Schwartz Least-Squares Monte Carlo, covered calls, momentum tilts, and regime-aware rebalancing. The final stage targets a 15% expected return. Portfolio performance is evaluated using correlated Geometric Brownian Motion with 20,000 Monte Carlo paths over a one-year horizon. The four-asset semivariance-optimized portfolio has a Sortino ratio of 2.04 and a maximum simulated loss of −23.7%, compared with 1.20 and −45.9% for SPY. Adding Asian and American puts increases the Sortino ratio to 2.26 and reduces maximum simulated loss to −8.8%. The 13-asset buy-and-hold portfolio reaches a mean Sortino ratio of 5.81. Among the rebalancing strategies tested, calendar rebalancing produced the highest mean Sortino ratio of 9.62. The 21-asset portfolio with a 15% return target has a Sortino ratio of 4.06 and maximum simulated loss of −28.8%; the full option overlay reduces the latter to −9.1%. These results characterize the tradeoffs among diversification, downside protection, return targets, and adaptive rebalancing within the simulated framework.
No takes yet. Share an insight, caveat, or question.
Antarik Bansal (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: